New FDA Policies Shape Pharma Development and Production

FDA is finalizing guidances and enforcing compliance with manufacturing standards as part of its efforts to ensure drug safety.

Related Content:

Process ValidationManufacturingQuality SystemsRegulatory WatchInformation TechnologyDevelopmentPharmaceutical Technology-05-02-2005

FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments

Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients

Increasing mRNA Product Stability with Lyophilization